Drug Type Oligonucleotide |
Synonyms- |
Target |
Mechanism miR-22 inhibitors(microRNA 22 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | US | - | |
Metabolic dysfunction-associated steatotic liver disease | Preclinical | US | - | |
Obesity | Preclinical | US | - |